International Prognostic Index for Chronic Lymphocytic Leukemia (CLL-IPI)
Use in newly diagnosed CLL patients
Loading...
Use in newly diagnosed CLL patients
References
- P. Langerbeins. Reassessing the Chronic Lymphocytic Leukemia International Prognostic Index in the era of targeted therapies.. Blood, 2024
- W. Wierda. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024.. Journal of the National Comprehensive Cancer Network : JNCCN, 2024
- P. Hampel. Chronic lymphocytic leukemia treatment algorithm 2022. Blood Cancer Journal, 2022
- E. Rotbain. CLL-IPI applied in Binet A CLL: a nationwide cohort study. Blood Advances, 2022
- Nina Kreuzberger. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.. The Cochrane database of systematic reviews, 2020
- B Eichhorst. Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.. Annals of oncology : official journal of the European Society for Medical Oncology, 2020
- S. Molica. Chronic lymphocytic leukemia international prognostic index: a systematic review and meta-analysis.. Blood, 2018
- NA. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data.. The Lancet. Oncology, 2016
- S. Molica. The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients. American Journal of Hematology, 2016
- M. Gentile. Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients.. Blood, 2016